Follow LF0 researchXLinkedInSubstackFacebookTelegram

The Scorecard: 3 Month Update: NUTX Buy — Incorrect so far

Revisiting our Buy call on NUTX: entry $188.41, latest $173.67, -7.8%.

This is a Scorecard review, revisiting a past LF0 research call against what actually happened.

Ticker: NUTX Rating: Buy Published: 2026-08-16 Checkpoint: 2026-11-16 Entry price: $188.41 Latest price: $173.67 as of 2026-11-13 Stock return since entry: -7.8% Signal return: -7.8% Verdict: Incorrect so far

This is the 3-month checkpoint for this call. LF0 publishes monthly Scorecard updates through month 6, using the closest available daily close on or before the checkpoint date.

Previous checkpoint: our 2-month review (2026-10-16) was incorrect (stock return -1.2% since entry). Each monthly review is judged on its own date, so the verdict can change from one month to the next.

Read the original LF0 analysis

What I Said

I rated NUTX a Buy because I thought the core issue was whether reimbursement risk was already overwhelming the cash engine, and the numbers I cited suggested it was not. My original case leaned on the company’s 15.6% FCF yield, 19.2% FCF margin, and 37.5% operating margin, while acknowledging a specific risk stack around IDR exposure, accrued arbitration expenses, and dilution from earn-outs and stock-based compensation.

Peer Comparison

CompanyReturn Since Entry
NUTX (this call)-7.8%
AMWL-6.8%
HIMS-34.0%
LFMD-42.2%
TDOC+31.8%
TEM+29.0%

How Other Analysts Rate It

Every Wall Street rating action logged on Yahoo Finance since our Buy on 2026-08-17, one row per action (a firm that updates three times appears three times). LF0 rows are in bold.

DateFirmRatingActionPrice target
2026-08-17LF0 Equity ResearchBuyOriginal call at $188.41
2026-09-04B. Riley SecuritiesBuyReiterated$325.00 (from $290.00)
2026-09-16LF0 Equity ResearchBuy1-month update
2026-09-25Freedom Capital MarketsBuyReiterated$306.00 (from $280.00)
2026-10-16LF0 Equity ResearchBuy2-month update
2026-10-26Ladenburg ThalmannBuyInitiated coverage$336.00
2026-11-09B. Riley SecuritiesBuyReiterated$357.00 (from $325.00)
2026-11-09Lake StreetBuyReiterated$333.00 (from $310.00)
2026-11-16LF0 Equity ResearchBuy3-month update (this report)

No analyst changed their rating on this stock since our Buy on 2026-08-17; the table shows reiterations and price-target changes only.

Counting each firm’s latest action in this window: 4 bullish, 0 neutral, 0 bearish out of 4 firms.

Yahoo’s consensus tally today: 6 Buy, 0 Hold, 0 Sell; three months ago: 5 Buy, 0 Hold, 0 Sell.

Source: Yahoo Finance analyst rating actions. Dates are when Yahoo logged the action. Analyst ratings are third-party opinions, not LF0 views or recommendations.

Why It’s Working (Or Not)

Over this tracking window, following my Buy would have lost 7.8%, so the call has not worked to date. The stock has moved lower while the peer set has been mixed, with several comparables also down but others, including TDOC and TEM, moving higher; that leaves NUTX looking weak, but not in a way that cleanly validates the bullish setup I described. The part of my thesis that has not held up is the idea that the current cash generation would be enough to absorb the reimbursement and dilution risks without the shares giving back value. The specific margin and yield figures I highlighted have not translated into a positive price outcome for the rating.

What Could Still Prove Me Wrong

If NUTX can re-establish the operating and free-cash-flow profile I pointed to in the original note, that would still be the clearest way to repair the thesis. A sustained move back above the 35% operating-margin level I cited, along with FCF margin staying comfortably above 10%, would show the cash engine is still strong enough to offset the reimbursement overhang. If instead those margins keep slipping while the dilution and arbitration burden remain visible, my Buy call stays wrong.

The August 2026 Cohort

Other directional calls published the same month:

TickerRatingEntryLatestStock ReturnSignal ReturnVerdict
SDGRSell$17.40$29.53+69.7%-69.7%Incorrect so far
GTNSell$4.83$5.99+24.0%-24.0%Incorrect so far
LHXSell$260.92$272.35+4.4%-4.4%Incorrect so far
VNOMSell$41.16$42.34+2.9%-2.9%Incorrect so far
AESSell$14.54$14.91+2.6%-2.6%Incorrect so far
PENNSell$18.56$17.50-5.7%+5.7%Correct so far
RRGBSell$9.51$8.81-7.4%+7.4%Correct so far
SPHRSell$147.34$125.56-14.8%+14.8%Correct so far
BASell$210.46$171.50-18.5%+18.5%Correct so far
NNDMSell$1.65$1.24-24.8%+24.8%Correct so far
NXESell$10.40$7.76-25.4%+25.4%Correct so far
OISell$6.79$4.96-27.0%+27.0%Correct so far
WGSSell$77.88$52.37-32.8%+32.8%Correct so far
LRCXSell$343.48$225.92-34.2%+34.2%Correct so far
ADTNSell$7.76$4.83-37.8%+37.8%Correct so far
STXSSell$1.39$0.84-39.6%+39.6%Correct so far
OWLTSell$5.81$3.44-40.8%+40.8%Correct so far
SRGStrong Sell$2.11$1.52-28.0%+41.9%Correct so far

Sector Scorecard: Healthcare

How are our Healthcare calls doing overall, and where does NUTX sit among them?

Peer callRatingPublishedSignal return
OWLTSell2026-08-12+40.8%
CUESell2026-09-02+40.2%
STXSSell2026-08-16+39.6%
WGSSell2026-08-09+32.8%
CRSPStrong Sell2026-10-26+20.7%
ABCLStrong Sell2026-11-09+12.1%
BFLYStrong Sell2026-11-02+1.5%
BSXBuy2026-06-14-5.1%

Across sectors, Technology led our league table with a 92% hit rate and +27.9% average signal return, followed by Industrials at 81% and +21.4%, while Financial Services posted a 100% hit rate on a thin 5 calls and +18.9%. Healthcare sat in the middle of the pack with 12 calls, a 58% hit rate, and +6.3% average signal return, with OWLT +40.8% as the best call and SDGR -69.7% as the worst. At the bottom, Communication Services lagged on +4.1% and Energy on +9.4%, while thin sectors such as Utilities, Real Estate, Consumer Defensive, and Unclassified were not ranked as leaders or laggards.

Sector League Table

SectorCallsHit rateAvg signal returnBestWorst
Technology2592%+27.9%CIFR +68.6%NLST -107.0%
Industrials1681%+21.4%BW +74.3%LUNR -35.4%
Financial Services5100%+18.9%HUT +41.5%BMNR +0.9%
Utilities333%+17.2%FLNC +67.5%TLN -13.3%
Basic Materials580%+14.1%LAR +45.1%MP -5.2%
Consumer Cyclical4100%+10.3%OI +27.0%FLUT +1.2%
Energy667%+9.4%BORR +23.0%SM -18.9%
Healthcare1258%+6.3%OWLT +40.8%SDGR -69.7%
Communication Services560%+4.1%LUMN +39.7%GTN -24.0%
Real Estate*250%+10.6%SRG +41.9%SKYH -20.7%
Consumer Defensive*10%-1.6%PG -1.6%PG -1.6%
Unclassified*250%-7.6%NXE +25.4%FISV -40.5%

\* Fewer than 3 calls: not ranked.

Sector by Publish Month

SectorJun 2026Jul 2026Aug 2026Sep 2026Oct 2026Nov 2026
Technology+51.5% (2)+12.1% (7)+32.3% (3)+30.2% (6)+33.1% (7)—
Industrials+74.3% (1)+43.7% (5)+7.1% (2)+8.8% (3)+4.3% (3)-1.8% (2)
Healthcare-5.1% (1)—+7.1% (5)+40.2% (1)-2.9% (3)+6.8% (2)
Energy—+19.1% (1)-2.9% (1)+23.0% (1)+5.8% (3)—
Financial Services—+27.5% (3)——+8.4% (1)+3.8% (1)
Communication Services—+8.0% (1)-4.6% (2)-17.7% (1)+39.7% (1)—
Basic Materials—+1.8% (1)—+45.1% (1)+14.4% (2)-5.2% (1)
Consumer Cyclical——+13.3% (3)——+1.2% (1)
Utilities—+67.5% (1)-2.6% (1)—-13.3% (1)—
Unclassified——+25.4% (1)—-40.5% (1)—
Real Estate-20.7% (1)—+41.9% (1)———
Consumer Defensive—————-1.6% (1)

Each cell: average signal return to date of the calls published that month (calls in brackets). Signal return is direction-adjusted, so a positive number means our call is right.

Live LF0 scorecard: The Scorecard | Research Performance dashboard

Past performance does not guarantee future results. Nothing here is investment advice or a recommendation to buy or sell securities. Returns use LF0’s daily-close scorecard methodology.

Research disclaimer

This material is provided for research and educational purposes only. It is not investment advice, a recommendation, or an offer to buy or sell any security or strategy.

Leave a Comment

Your email address will not be published. Required fields are marked *